event tracking

VAI-SU2C Epigenetics Dream Team

38 results.

September 21, 2026 Phase 2 trial suggests vitamin C may benefit people with pre-cancer blood disorders

Highlights People with pre-cancer blood disorders and early-stage blood cancers who took daily doses of 1,000 mg oral vitamin C were significantly more likely to…

September 21, 2026 What is vitamin C and why are cancer researchers interested in it?

Highlights Vitamin C is an essential nutrient that we obtain by eating foods like citrus fruits and leafy greens. It supports several important systems and…

February 4, 2026 Cancer research in 2026: What’s new? What’s next?

Cancer research saves lives.

For the first time, the five-year survival rate for all cancers combined has hit 70% among people diagnosed from 2015–2021 in…

December 19, 2025 Reflecting on research: 2025 highlights

In 2025, VAI continued to build scientific momentum and drive discoveries that deepen our understanding of human health. With the addition of new faculty and…

December 16, 2024 VAI Research: A year in review

The past year at Van Andel Institute can be summed up in two words: “growth” and “impact.”

We’ve expanded our research capacity by adding new…

October 10, 2024 Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy

MEMPHIS, Tenn. (Oct. 10, 2024) — Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but…

June 26, 2024 New research aims to improve cancer immunotherapy

To say that immunotherapies have been a game-changer for cancer feels like an incredible understatement.  

These powerful treatments, which work by bolstering the immune…

March 27, 2024 Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

GRAND RAPIDS, Mich. (March 27, 2024) — A pair of medications that make malignant cells act as if they have a virus could hold new promise for…